Xavier Leroy

Xavier Leroy, PhD, is a seasoned executive with extensive experience in biotechnology and pharmaceuticals. Currently serving as Chief Executive Officer at GIO Therapeutics and Founder & CEO at Ankyo, Xavier also holds the role of Executive in Residence at Cumulus Oncology and President at the Biodiversity Heritage Site « Jean & Marie-Claire Leroy ». With a robust background in scientific leadership, Xavier has previously worked as Chief Scientific Officer at Domain Therapeutics and Chief Technology Officer at iTeos Therapeutics SA, among other notable positions. Educational credentials include a PhD in Biology & Pharmacology from Université de Bretagne Occidentale and an Executive MBA from HEC Paris. Xavier has actively contributed to various European research networks and has significant expertise in drug discovery and project leadership within renowned organizations.